Hepatitis C Awareness - Shorter Therapy Effective for Genotypes 2 and 3

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...

Pegasys Shown More Effective In Study
Schering and Roche are taking part in dueling press releases. Each claiming their solution is better. Either way, they seem to be splitting hairs regarding effectiveness. There is no clear winner when they keep firing PR salvos back and forth....

Weight-based Treatment of HCV
Weight-based dosing has always made sense to us. We don't really understand why Roche has not changed their dosing to weight-based. Although the difference is subtle, it is certainly significant according to this study. You must also note, though, that...